Searched for
RAJARAM NARAYANAN
AI can handle the 'how', OpenAI VP tells engineers to focus on 'what' & 'why': Here’s what every developer should knowAt Sangam 2025, OpenAI and Microsoft leaders emphasized the evolving role of software engineers, urging them to prioritize problem definiti...- Carlyle portfolio firms SeQuent Scientific and Viyash Life get stock exchange nod for mergerCarlyle-backed SeQuent Scientific and Viyash Life Sciences have secured stock exchange approvals for their merger. Next, they will approach...
- Sequent to absorb Viyash, giving 56 for 100 sharesIn a stock exchange filing, Sequent Scientific said its board has approved a proposal to merge Viyash Life Sciences and its group companies...
- Sequent Scientific shares soar 18% on Rs 8,000 crore merger with Viyash Life SciencesSequent Scientific and Viyash Life Sciences have announced a merger that will result in the two companies forming a combination that will c...
- Sequent Scientific, Viyash Life Sciences announce Rs 8,000 crore mergerSequent Scientific and Viyash Life Sciences have announced a merger, creating a platform with leadership in animal pharmaceuticals and inte...
- Padma Awards 2024: Full list of winners to be conferred with Padma Vibhushan, Padma Bhushan and Padma ShriPadma Awards 2024: The Padma Awards for 2024 are set to honor 132 distinguished individuals with India's highest civilian honors. The prest...
- Drug discovery startup Peptris raises $1 million funding from Speciale Invest, othersUsing advanced AI, Peptris sifts through large data sets to identify and develop potential drug candidates quickly and cost-effectively, re...
- Buy Sanofi India, target price Rs 6200: Sharekhan by BNP ParibasSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13232.93 Crore) operating in Pharmaceuticals s...
- Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
- Buy Sequent Scientific, target price Rs 130: Yes SecuritiesAlso bring in FY25 forecast and, while the brokerage still remains positive despite the sharp cuts, reckon recovery is firmly delayed by a ...
- Stocks in the news: UltraTech, HDFC Bank, HCL Tech, IOC, Maruti and SAILUltraTech Cement, HFCL, Angel One, Sonata Software, Hathway Cable, Tatva Chintan Pharma Chem and Maharashtra Scooters are among the compani...
- Stocks in the news: RIL, Paytm, Titan, HCL Tech, Tata Motors and HALHCL Tech, Tinplate Company, Onward Technologies, Swasti Vinayaka Synthetics, International Travel House and Gujarat Hotels are among the co...
- Sanofi India's managing director Rajaram Narayanan steps down"In these roles, he has led the strategic reorientation of the organisation, sharpening its focus on core areas, developing new business mo...
- Encube Ethicals to buy Soframycin for Rs 125 crore for India & SL marketsEncube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...
- Buy Sanofi, target price Rs 7,170: Dharmesh ShahDharmesh Shah recommended to keep stoploss at Rs 6650.
- Ex-Infosys employees come out in Narayana Murthy’s support, slam Infy BoardIn the scathing letter, the former employees of the IT company highlighted the sacrifices of the founders and the importance of core values.
Load More
